HUTCHMED (China) (HMDCF) Change in Working Capital (2020 - 2021)

HUTCHMED (China) (HMDCF) reported Change in Working Capital of $1.5 million for Q1 2021, up 187.08% year-over-year from $511000.0 in Q1 2020, and up 187.08% quarter-over-quarter from $511000.0 in Q1 2020.

HUTCHMED (China) (HMDCF) Change in Working Capital (2020 - 2021) Analysis & Trends

HUTCHMED (China) (HMDCF) has 2 years of Change in Working Capital data on file, last reported at $1.5 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Working Capital (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -617.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 215.05 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 HUTCHMED (China) - - - -

Historic Data

Download Data
DateValue
Mar 31, 2021 1.47 Mn
Mar 31, 2021 1.47 Mn
Mar 31, 2020 511,000.00
Mar 31, 2020 511,000.00